BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 29770496)

  • 1. Long-term survival and loss in expectancy of life in a population-based cohort of 7114 patients with diffuse large B-cell lymphoma.
    Ekberg S; Jerkeman M; Andersson PO; Enblad G; Wahlin BE; Hasselblom S; Andersson TM; Eloranta S; Smedby KE
    Am J Hematol; 2018 May; ():. PubMed ID: 29770496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diffuse large B-cell lymphoma.
    Martelli M; Ferreri AJ; Agostinelli C; Di Rocco A; Pfreundschuh M; Pileri SA
    Crit Rev Oncol Hematol; 2013 Aug; 87(2):146-71. PubMed ID: 23375551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of venous thromboembolism and predictive ability of age-adjusted international prognostic index for prediction of venous thromboembolism in Asian patients with diffuse large B-cell lymphoma.
    Hantrakun N; Phinyo P; Tantiworawit A; Rattarittamrong E; Chai-Adisaksopha C; Rattanathammethee T; Hantrakool S; Piriyakhuntorn P; Punnachet T; Niprapan P; Norasetthada L
    J Thromb Thrombolysis; 2024 Mar; 57(3):473-482. PubMed ID: 38091158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapeutic intensity and survival differences in young patients with diffuse large B-cell lymphoma: a Swedish Lymphoma Registry study.
    Melén CM; Enblad G; Sonnevi K; Junlén HR; Smedby KE; Jerkeman M; Wahlin BE
    Br J Haematol; 2016 Nov; 175(4):614-622. PubMed ID: 27790699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of frontline autologous stem cell transplantation in young, high-risk diffuse large B-cell lymphoma patients.
    Yoon JH; Kim JW; Jeon YW; Lee SE; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Min WS; Park CW; Cho SG
    Korean J Intern Med; 2015 May; 30(3):362-71. PubMed ID: 25995667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increase in the Life Expectancy of Patients with Cancer in the United States.
    Devasia TP; Howlader N; Dewar RA; Stevens JL; Mittu K; Mariotto AB
    Cancer Epidemiol Biomarkers Prev; 2024 Feb; 33(2):196-205. PubMed ID: 38015774
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation.
    Lee HG; Kim SY; Kim I; Kim YK; Kim JA; Kim YS; Lee HS; Park J; Kim SJ; Shim H; Eom HS; Park BB; Lee J; Park SK; Cheong JW; Park KW
    Blood Res; 2015 Sep; 50(3):160-6. PubMed ID: 26457283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The International Prognostic Index Is Associated with Outcomes in Diffuse Large B Cell Lymphoma after Chimeric Antigen Receptor T Cell Therapy.
    Garcia-Recio M; Wudhikarn K; Pennisi M; Alonso-Trillo R; Flynn J; Shouval R; Afuye AO; Silverberg ML; Batlevi CW; Dahi P; Devlin S; Giralt SA; Halton E; Ruiz J; Maloy M; Mead E; Palomba ML; Santomasso B; Sauter CS; Scordo M; Shah GL; Perales MA
    Transplant Cell Ther; 2021 Mar; 27(3):233-240. PubMed ID: 33781518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. R-CHOP chemoimmunotherapy followed by autologous transplantation for the treatment of diffuse large B-cell lymphoma.
    Lee HG; Choi Y; Kim SY; Kim I; Kim YK; Kim YS; Lee HS; Kim SJ; Kim JA; Park BB; Park J; Shim H; Eom HS; Lee J; Park SK; Cheong JW; Park KW
    Blood Res; 2014 Jun; 49(2):107-14. PubMed ID: 25025012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics and Prognostic Factors in Primary Breast Diffuse Large B-Cell Lymphoma.
    Chen GL; Li D; Cao S; Jiang S; Zhang Q; Jin J; Xia Z; Liu Y; Liu X; Zhu Y; Chen Y; Gu L; Hong X; Cao J; Tao R; Lv F
    Mediterr J Hematol Infect Dis; 2022; 14(1):e2022066. PubMed ID: 36119461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal improvements noted in life expectancy of patients with colorectal cancer; a Dutch population-based study.
    Qaderi SM; Andersson TML; Dickman PW; de Wilt JHW; Verhoeven RHA
    J Clin Epidemiol; 2021 Sep; 137():92-103. PubMed ID: 33836257
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Nomogram for Overall Survival in Patients with Diffuse Large B-Cell Lymphoma.
    Han Y; Yang J; Liu P; He X; Zhang C; Zhou S; Zhou L; Qin Y; Song Y; Sun Y; Shi Y
    Oncologist; 2019 Nov; 24(11):e1251-e1261. PubMed ID: 30952824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. BCL2 Expression in First-Line Diffuse Large B-Cell Lymphoma Identifies a Patient Population With Poor Prognosis.
    Punnoose E; Peale FV; Szafer-Glusman E; Lei G; Bourgon R; Do AD; Kim E; Zhang L; Farinha P; Gascoyne RD; Munoz FJ; Martelli M; Mottok A; Salles GA; Sehn LH; Seymour JF; Trnĕný M; Oestergaard MZ; Mundt KE; Vitolo U
    Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):267-278.e10. PubMed ID: 33303421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognostic analysis of 525 Chinese patients with diffuse large B cell lymphoma].
    Fu ZY; Zhu J; Song YQ; Liu WP; Ji XQ; Zhan SY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Jun; 46(3):405-11. PubMed ID: 24943019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognosis of localized diffuse large B-cell lymphoma in younger patients.
    Møller MB; Christensen BE; Pedersen NT
    Cancer; 2003 Aug; 98(3):516-21. PubMed ID: 12879468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 18. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
    Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
    JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes among 2-year survivors of autologous hematopoietic cell transplantation for Hodgkin and diffuse large b-cell lymphoma.
    Myers RM; Hill BT; Shaw BE; Kim S; Millard HR; Battiwalla M; Majhail NS; Buchbinder D; Lazarus HM; Savani BN; Flowers MED; D'Souza A; Ehrhardt MJ; Langston A; Yared JA; Hayashi RJ; Daly A; Olsson RF; Inamoto Y; Malone AK; DeFilipp Z; Margossian SP; Warwick AB; Jaglowski S; Beitinjaneh A; Fung H; Kasow KA; Marks DI; Reynolds J; Stockerl-Goldstein K; Wirk B; Wood WA; Hamadani M; Satwani P
    Cancer; 2018 Feb; 124(4):816-825. PubMed ID: 29125192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
    Wang S; Wang L; Hu J; Qian W; Zhang X; Hu Y; Zhu Q; Chen B; Wu D; Chang CH; Xu P; Zheng X; Wei J; Liu Y; Cui G; Tang Y; Ma Y; Huang H; Yi H; Zhao W
    Cancer Commun (Lond); 2021 Mar; 41(3):229-239. PubMed ID: 33482051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.